VIB1116 for Rheumatic Diseases

"The criteria for participation in this clinical trial necessitates that applicants are between 18 and 65 years of age. Patients younger than 18 have access to 9 studies, while those over 65 can partake in 36 different trials."

"This research endeavour is seeking 72 participants with collagen-related issues aged between 18 and 65. Their BMI must be lower than 30 kg/m², or for those who have received the COVID-19 vaccine in the last month their BMI must not exceed 35 kg/m^2. Additionally, they need to have been diagnosed with a rheumatologic disorder at least 6 months ago and had consistent treatment (or none) of glucocorticoid or DMARDs over the prior 4 weeks; finally, all involved parties are required to adhere to contraceptive protocols outlined by this study."

"In order to effectively run this medical trial, 72 eligible candidates are required. The study is conducted from multiple research sites such as Accurate Clinical Research in Lake Charles and Pinnacle Research Group based in Anniston, Alabama."

"Clinicaltrials.gov lists this clinical trial as currently open, with the original posting being on July 6th 2021 and its most recent edit occurring on September 22nd 2022."

"The safety profile of VIB1116 was ranked 1, as this is an initial phase trial that lacks substantial evidence for both efficacy and safety."

"Currently, 8 medical centres are accepting patients for the trial. These sites include Lake Charles, Anniston and San Antonio plus 5 more locations across the country. It may be useful to prioritize nearby destinations when deciding on a test site in order to reduce travel commitments."